Publications by authors named "H Oral"
Catheter Ablation of Parahisian Premature Ventricular Complexes From the Right Sinus of Valsalva.
J Cardiovasc Electrophysiol
December 2024
Article Synopsis
- Cather ablation of parahisian PVCs often involves targeting the right sinuses of Valsalva (SoV), but there's limited data on its safety and effectiveness.
- * The study examined 11 male patients (average age 68) undergoing PVC ablation in the right SoV, finding that all had intramural LGE-CMR scar involvement, which affected the success rate.
- * Results showed that 91% of the patients had a successful reduction in PVC burden after the procedure, even though traditional indicators of success were not always present at the effective ablation sites.
New biological markers in diagnosis and follow-up of brucellosis cases.
Diagn Microbiol Infect Dis
February 2025
Brucellosis remains a significant public health issue in some parts of the world. It is clear that new laboratory methods are needed to diagnose brucellosis. Currently, no test method meets the criteria of high specificity, sensitivity, reliability, and low cost for the diagnosis of brucellosis, which could also predict chronicity.
View Article and Find Full Text PDFThis study aims to investigate the effectiveness of non-invasive fibrosis markers in predicting varices in compensated advanced chronic liver disease patients and variceal bleeding in decompensated cirrhotic patients. Between 1 July 2020-2021, 137 newly diagnosed cirrhosis patients (67 females/70 males; mean age: 53.35) were included in the study.
View Article and Find Full Text PDFArticle Synopsis
- - Dofetilide, a class III antiarrhythmic, is used to treat atrial fibrillation and flutter, and has been applied off-label for ventricular arrhythmias like PVCs and VTs.
- - In a study involving 81 patients, dofetilide initiation showed a significant decrease in PVC burden, but was discontinued in some cases due to QT prolongation and lack of efficacy.
- - Overall, 72% of patients had to stop dofetilide due to inefficacy or intolerance, and there was no significant difference in event-free survival between those treated with dofetilide and those who weren't.